These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16156695)

  • 1. Free antiretrovirals must not be restricted only to treatment-naive patients. Experience in Uganda suggests that restricting access is not the way forward.
    Colebunders R; Kamya M; Semitala F; Castelnuovo B; Katabira E; McAdam K
    PLoS Med; 2005 Oct; 2(10):e276. PubMed ID: 16156695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.
    Rosen S; Sanne I; Collier A; Simon JL
    PLoS Med; 2005 Nov; 2(11):e303. PubMed ID: 16159308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy in resource-poor settings: scaling up inequalities?
    Egger M; Boulle A; Schechter M; Miotti P
    Int J Epidemiol; 2005 Jun; 34(3):509-12. PubMed ID: 15941732
    [No Abstract]   [Full Text] [Related]  

  • 4. Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver.
    Greenbaum JL
    J Contemp Health Law Policy; 2008; 25(1):142-65. PubMed ID: 19137750
    [No Abstract]   [Full Text] [Related]  

  • 5. Access to HIV treatment improves.
    AIDS Patient Care STDS; 2008 Jun; 22(6):535-6. PubMed ID: 18582191
    [No Abstract]   [Full Text] [Related]  

  • 6. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G8 failure on AIDS funding 'obscene'.
    Bateman C
    S Afr Med J; 2009 Sep; 99(9):624-5. PubMed ID: 20073281
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the costs of pharmaceuticals.
    Valenti WM
    AIDS Read; 2004 Sep; 14(9):467-8, 471. PubMed ID: 15457597
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
    Ojikutu B
    J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS drug programs tighten belts even as medications are shown to curb contagion.
    Trubo R
    JAMA; 2011 Jul; 306(3):253-5. PubMed ID: 21771980
    [No Abstract]   [Full Text] [Related]  

  • 11. World Health Organization and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005.
    Ann Saudi Med; 2004; 24(1):71-2. PubMed ID: 15310026
    [No Abstract]   [Full Text] [Related]  

  • 12. Approaches to rationing antiretroviral treatment: ethical and equity implications.
    Bennett S; Chanfreau C
    Bull World Health Organ; 2005 Jul; 83(7):541-7. PubMed ID: 16175829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Launch of AIDS fund for Red Cross staff.
    Kapp C
    Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672080
    [No Abstract]   [Full Text] [Related]  

  • 14. Scaling up AIDS treatment: what is the potential impact and what are the risks?
    Lamptey P; Wilson D
    PLoS Med; 2005 Feb; 2(2):e39. PubMed ID: 15740413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanhood predicts delayed access to care in Ugandan children.
    Ntanda H; Olupot-Olupot P; Mugyenyi P; Kityo C; Lowes R; Cooper C; Lima V; Mills E
    Pediatr Infect Dis J; 2009 Feb; 28(2):153-5. PubMed ID: 19131904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARV prices nosedive after Clinton brokering.
    Sharma DC
    Lancet; 2003 Nov; 362(9394):1467. PubMed ID: 14603929
    [No Abstract]   [Full Text] [Related]  

  • 17. Generics for AIDS.
    Nat Immunol; 2004 Nov; 5(11):1089. PubMed ID: 15496942
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of antiretroviral treatments in Europe: the Italian experience.
    Rizzardini G; Restelli U; Croce D
    AIDS; 2013 Sep; 27(14):N3-6. PubMed ID: 24157911
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact and cost of ending AIDS in Botswana.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet HIV; 2016 Sep; 3(9):e409. PubMed ID: 27562741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.